Association between stasis dermatitis and length of stay in heart failure hospitalizations

Basit Öğe Kaydı
dc.contributor.authorKaya, Ozge
dc.contributor.authorSahin, Anil
dc.contributor.authorKaya, Hakki
dc.date.accessioned2025-01-27T19:00:36Z
dc.date.available2025-01-27T19:00:36Z
dc.date.issued2020
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractBackground: Stasis dermatitis (SD) is caused by venous hypertension that can be associated with peripheral congestion due to heart failure (HF). Length of stay (LOS) is the primary driver of HF hospitalization costs. Therefore, it is important to determine those patients who will have longer LOS. We aimed to investigate the relationship between the SD and LOS in HF patients. Methods: A total of 308 patients, who were hospitalized between January 2012 and January 2014 due to acute decompensated HF (ADHF) in our center, were evaluated in this retrospective observational cohort study. Patients' baseline clinical characteristics and presence of SD diagnosis within the past 3 months prior the HF hospitalization were assessed by a review of cardiology and dermatology clinics medical records. Results: A total of 237, acutely decompensated, HF patients were enrolled in the study. The median LOS was 5 days, and the mean LOS was 5.4 ± 2 days. Prolonged LOS was defined as LOS >5 days, and the patients were classified into two groups: Those with LOS ?5 days (Group I) and those with LOS >5 days (Group II, longer LOS). The presence of SD diagnosis was higher in Group II compared to patients in Group I (22% vs. 46%, P < 0.001). In the multivariate logistic regression model, presence of SD diagnosis, presence of moderate-to-severe tricuspid regurgitation, presence of atrial fibrillation, left atrial diameter, creatinine level, sodium level remained associated with longer LOS after adjustment for age, gender and for the variables found to be statistically significant in univariate analysis and correlated with LOS. Conclusions: This was the first time in the literature that a study demonstrated that the presence of SD was associated with an increased the risk of prolonged hospitalization independent of other factors in patients with reduced ejection fraction heart failure admitted for ADHF. © 2020 Society of Cardiovascular Academy. All rights reserved.
dc.identifier.doi10.4103/IJCA.IJCA_12_20
dc.identifier.endpage85
dc.identifier.issn2405-819X
dc.identifier.issue2
dc.identifier.scopus2-s2.0-85187129026
dc.identifier.scopusqualityQ4
dc.identifier.startpage80
dc.identifier.urihttps://doi.org/10.4103/IJCA.IJCA_12_20
dc.identifier.urihttps://hdl.handle.net/20.500.12428/13399
dc.identifier.volume6
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherWolters Kluwer Medknow Publications
dc.relation.ispartofInternational Journal of the Cardiovascular Academy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20250125
dc.subjectAcute heart failure; congestion; length of stay; stasis dermatitis
dc.titleAssociation between stasis dermatitis and length of stay in heart failure hospitalizations
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu